Épisodes

  • Ep.119 – New Rules for Old Infections: What the DOTS Trial Tells Us
    Aug 22 2025
    Episode Notes

    Join DASON Clinical Pharmacist Liaison Jeannette Bouchard as she speaks with Dr. Nick Turner, lead author of the DOTS randomized clinical trial, about the potential of dalbavancin as a simplified treatment for Staphylococcus aureus bacteremia. They discuss the trial’s findings, its implications for clinical practice, and whether two doses can truly replace weeks of IV antibiotics. The materials reviewed in this episode can be found here: https://dason.medicine.duke.edu/blog/new-rules-old-infections-what-dots-trial-tells-us

    For more information about DASON, please visit: https://dason.medicine.duke.edu

    Voir plus Voir moins
    31 min
  • Ep.118 – Combatting unnecessary ASB treatment through diagnostic stewardship – which approach works?
    Aug 8 2025
    Episode Notes

    In this episode, Dr. Melissa Johnson, one of our DASON Clinical Pharmacist Liaisons, talks with Dr. Kim Claeys, from the University of Maryland, about her recent work on the implementation diagnostic stewardship to improve UTI antibiotic use. The two publications referenced in this episode can be found here: https://pubmed.ncbi.nlm.nih.gov/40720743/ and here: https://pubmed.ncbi.nlm.nih.gov/37424224/

    For more information about DASON, please visit: https://dason.medicine.duke.edu/

    Voir plus Voir moins
    30 min
  • Ep.117 – Nurse-Driven PEN-FAST Allergy De-labeling
    Jul 25 2025
    Episode Notes

    In this episode of the DASON Digest podcast, DASON Clinical Pharmacist Liaison, Dr. April Dyer, talks to us about an article in Antimicrobial Stewardship & Healthcare Epidemiology entitled "Implementation and performance of a nurse administered modified PEN-FAST clinical decision rule in the electronic health record." The article can be found here: https://pubmed.ncbi.nlm.nih.gov/40697885/

    For more information about DASON, please visit: https://dason.medicine.duke.edu/

    Voir plus Voir moins
    17 min
  • Ep.116 – Cascade Reporting Under the Microscope: Two Sides, One Debate
    Jul 14 2025
    Episode Notes

    Join host DASON Clinical Pharmacist Liaison Dr. Libby Dodds Ashley as she as talks with Dr. Emily Heil and Dr. Joe Kuti to review the recent article published in the Journal of Clinical Microbiology titled: “Point-Counterpoint: Cascade Reporting—Useful Tool to Support Antimicrobial Stewardship, or Dangerously Misleading?” Together, they explore the practical and controversial aspects of cascade reporting. The article reviewed in this episode can be found here: https://pubmed.ncbi.nlm.nih.gov/40526395/

    For more information about DASON, please visit: https://dason.medicine.duke.edu/

    Voir plus Voir moins
    23 min
  • Ep.115 – Septic Shock and AKI: Do we still need to worry about piperacillin-tazobactam?
    Jun 27 2025
    Episode Notes

    In this episode of the DASON Digest podcast, DASON clinical pharmacist liaison Dr. Angelina Davis talks with us about a national retrospective cohort study comparing the effects of cefepime versus piperacillin-tazobactam on the development of severe acute kidney injury in patients with septic shock. The article for this episode can be found here: https://pubmed.ncbi.nlm.nih.gov/39657005/

    For more information about DASON, please visit: https://dason.medicine.duke.edu/

    Voir plus Voir moins
    16 min
  • Ep.114 – Procalcitonin in Practice: Evaluating Its Impact on CAP Management
    Jun 13 2025
    Episode Notes

    Join DASON Liaison Jeannette Bouchard as she hosts Dr. Dan Ilges and Dr. Ryan Stevens to discuss the recent article published in Infection Control & Hospital Epidemiology titled: “Real-world Utility of Procalcitonin in Patients Hospitalized with Community-Acquired Pneumonia: A Matched Cohort Study.” Together, they unpack how this study challenges the utility of procalcitonin in guiding antibiotic use for CAP, explores implications for diagnostic stewardship, and reflects on strategies to optimize antimicrobial decision-making in inpatient care.

    The articles reviewed in this episode can be found here: https://pubmed.ncbi.nlm.nih.gov/40017121/ and here: https://www.fda.gov/media/100879/download

    For more information about DASON, please visit: https://dason.medicine.duke.edu/

    Voir plus Voir moins
    31 min
  • Ep.113 – Are You Ready for It? Assessing Cephalosporin Allergies with the CEPH-FAST Score
    May 30 2025

    Episode Notes

    In this episode, DASON Clinical Pharmacist Liaison Dr. Melissa Johnson talks with Dr. Jason Trubiano, Director of Infectious Diseases at Austin Health in Australia. Drs. Johnson and Trubiano discuss an article in Journal of Infection entitled "Development and validation of a cephalosporin allergy clinical decision rule." The article can be found here: https://pubmed.ncbi.nlm.nih.gov/40288499/

    For more information about DASON, please visit: https://dason.medicine.duke.edu/

    Voir plus Voir moins
    25 min
  • Ep.112 – (Re)moving the needle: implementation of an institutional IV to PO treatment guidance for bone and joint infections
    May 16 2025
    Episode Notes

    Join DASON Clinical Pharmacist Liaison Dr. Jeannette Bouchard as she reviews the recent article published in Antimicrobial Stewardship & Healthcare Epidemiology titled: (Re)Moving the Needle: A Retrospective, Quasi-Experimental Assessment of the Impact of a Treatment Guideline on Oral Antibiotic Prescribing for Orthopedic Infections." She discusses how this study highlights the real-world impact of guideline implementation on shifting antibiotic prescribing practices for bone and joint infections. The article reviewed in this episode can be found here: https://pubmed.ncbi.nlm.nih.gov/40160226/

    For more information about DASON, please visit: https://dason.medicine.duke.edu/

    Voir plus Voir moins
    10 min